Corcept Therapeutics CORT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $109.99M-9.7% | $121.75M-2.7% | $125.14M+21.8% | $102.75M+13.1% | $90.82M-29.4% | ||
| $229.45M-8.8% | $251.66M-15.1% | $296.55M+23.8% | $239.48M+2.8% | $232.94M-8.9% | ||
| $39.07M-34.6% | $59.79M-14.1% | $69.63M+7.8% | $64.57M+4.4% | $61.82M+14.5% | ||
| $14.51M+30.8% | $11.09M-7.6% | $12M+50.2% | $7.99M+585% | $1.17M-67.5% | ||
| $426.03M-12.2% | $485.46M-10.3% | $541.13M+22.1% | $443.11M+1.1% | $438.5M-7.0% | ||
| $3.17M+67.8% | $1.89M-9.7% | $2.09M-10.8% | $2.35M-7.7% | $2.54M-5.4% | ||
| $814.88M-2.6% | $836.65M+1.6% | $823.61M+2.7% | $801.72M-5.3% | $846.46M+0.7% | ||
| $33.31M-17.6% | $40.44M+17.4% | $34.45M+46.4% | $23.53M-15.8% | $27.95M+81.8% | ||
| $149.19M-10.2% | $166.09M-3.6% | $172.27M+19.1% | $144.66M+1.1% | $143.07M+1.6% | ||
| $176.89M-6.3% | $188.85M-1.5% | $191.71M+15.5% | $165.93M+1.7% | $163.17M+1.4% | ||
| $141K+0.7% | $140K+0.7% | $139K+0.7% | $138K+0.7% | $137K+0.7% | ||
| $611.63M-4.9% | $643.39M+3.9% | $619.1M+3.3% | $599.43M+6.2% | $564.28M+3.8% | ||
| $637.99M-1.5% | $647.81M+2.5% | $631.9M-0.6% | $635.79M-7.0% | $683.29M+0.5% | ||
| $814.88M-2.6% | $836.65M+1.6% | $823.61M+2.7% | $801.72M-5.3% | $846.46M+0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corcept Therapeutics's total assets?
- Corcept Therapeutics (CORT) holds $814.9M in total assets, down 3.7% year over year.
- How much debt does Corcept Therapeutics have?
- Corcept Therapeutics carries $9.6M in total debt against $638.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Corcept Therapeutics have?
- Corcept Therapeutics holds $110.0M in cash and equivalents.
- Can Corcept Therapeutics cover its short-term obligations?
- Its current ratio is 2.86 — current assets exceed current liabilities.
- Where does Corcept Therapeutics's balance sheet data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
